Exosomes are one of the most talked-about and most misunderstood categories in aesthetics right now. Before adding any exosome product to your menu, it's essential to understand the UK regulatory position, which is stricter than the marketing around exosomes often suggests.
What are exosomes?
Exosomes are tiny vesicles released by cells that carry proteins, lipids and genetic material, acting as messengers in cell-to-cell communication. In aesthetics they are most commonly discussed in the context of supporting recovery after procedures such as microneedling or laser.
The UK regulatory position — read this first
This is the part that matters most for practitioners:
-
The MHRA treats injected exosomes as medicinal products, and injecting them — intradermally, subcutaneously or intravenously — is not lawful in UK aesthetic procedures.
-
No exosome injectable currently holds a UK marketing authorisation.
-
Topical application (for example, applied to the skin after microneedling) is the route generally regarded as permissible.
-
Any product used should be CE marked; non-CE-marked or human-derived injectable exosomes raise serious safety and legal concerns and can invalidate insurance.
Because the regulatory and safety picture is evolving and has prompted public warnings, practitioners should treat any suggestion of injecting exosomes as a red flag and keep up to date with current MHRA guidance.
How Luxia Exosomes fit in
Within these boundaries, exosome products are used by practitioners as part of compliant, topical protocols. Stick to the manufacturer's instructions, confirm CE marking, and make sure your consent and record-keeping reflect the actual treatment being delivered.
Ordering in the UK
The Luxia Exosomes products — for hair and skin — sit within the wider Luxia range at SK Clinical Distributions, for registered practitioners. Trade pricing is shown after logging in.